Zydus Cadila gets USFDA nod to market generic cancer drug in US

Drug firm Zydus Cadila on Saturday said it has received approval from US health regulator to market Decitabine injection, used to treat certain types of cancers, in American market.

company has received final approval from US Food and Drug Administration (USFDA) to Decitabine for Injection in strength of 50 mg/vial single-dose vial, Zydus Cadila said in a statement.

Decitabine is used to treat myelodysplastic syndromes, certain types of blood or bone marrow cancer.

drug will be manufactured at group's injectables manufacturing facility, drugmaker said.

Zydus group w has 326 approvals and has so far filed over 400 abbreviated new drug applications (ANDAs) since commencement of filing process in 2003-04, it added. 

(Im: PTI/Unsplash)